[
    [
        {
            "time": "2020-06-29",
            "original_text": "恒瑞医药：钧鸣生命科学多策略私募证券投资基金已完成备案",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "私募基金",
                    "备案"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药：钧鸣生命科学多策略私募证券投资基金已完成备案",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "上半年十大牛股排名出炉 大涨前谁推荐了？",
            "features": {
                "keywords": [
                    "牛股",
                    "排名",
                    "推荐"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上半年十大牛股排名出炉 大涨前谁推荐了？",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "投资人视角丨国家联采办“拍了拍”各大药企，第三批药品集采工作蓄势待发！",
            "features": {
                "keywords": [
                    "国家联采办",
                    "药品集采",
                    "药企"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "投资人视角丨国家联采办“拍了拍”各大药企，第三批药品集采工作蓄势待发！",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "资金流向复盘｜北水买入腾讯，卖出美团点评、中芯国际",
            "features": {
                "keywords": [
                    "北水",
                    "腾讯",
                    "美团",
                    "中芯国际"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "互联网"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "资金流向复盘｜北水买入腾讯，卖出美团点评、中芯国际",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "海正药业：盐酸伊立替康注射液注册申请主动撤回并获得批准",
            "features": {
                "keywords": [
                    "海正药业",
                    "盐酸伊立替康",
                    "撤回",
                    "批准"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "海正药业：盐酸伊立替康注射液注册申请主动撤回并获得批准",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "国产 PD-1 正迎来密集收获期，这些药企被看好",
            "features": {
                "keywords": [
                    "PD-1",
                    "药企",
                    "收获期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国产 PD-1 正迎来密集收获期，这些药企被看好",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "Wind快讯 | 每日医药行业动态（2020-6-29）",
            "features": {
                "keywords": [
                    "医药",
                    "行业动态"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Wind快讯 | 每日医药行业动态（2020-6-29）",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "恒瑞医药：多名高管合计减持0.0033%股份 减持股份",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "高管",
                    "减持"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药：多名高管合计减持0.0033%股份 减持股份",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "恒瑞医药：董监高孙辉、刘疆、孙绪根减持17万股 陶维康未减持 减持计划已完成",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "董监高",
                    "减持"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药：董监高孙辉、刘疆、孙绪根减持17万股 陶维康未减持 减持计划已完成",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-29",
            "original_text": "701亿资金争夺20股：主力资金重点出击4股(名单)",
            "features": {
                "keywords": [
                    "资金",
                    "主力",
                    "出击"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "701亿资金争夺20股：主力资金重点出击4股(名单)",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]